Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Sangamo Therapeutics's market cap was $32.62M on Oct 19, 2026, against $135.27M a year earlier. Over the last 5 years it ranged from $17.37M to $1.19B, with a median of $160.76M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $32.62M | -68.7% |
| 2025 | Dec 31, 2025 | $104.13M | -47.4% |
| 2024 | Dec 31, 2024 | $197.95M | +113.9% |
| 2023 | Dec 29, 2023 | $92.54M | -80.3% |
| 2022 | Dec 30, 2022 | $469.56M | -56.4% |
| 2021 | Dec 31, 2021 | $1.08B | -46.1% |
| 2020 | Dec 31, 2020 | $2.00B | +119.7% |
| 2019 | Dec 31, 2019 | $909.47M | -22.2% |
| 2018 | Dec 31, 2018 | $1.17B | -15.2% |
| 2017 | Dec 29, 2017 | $1.38B | +540.4% |
| 2016 | Dec 30, 2016 | $215.40M | -66.3% |
| 2015 | Dec 31, 2015 | $639.49M | -38.5% |
| 2014 | Dec 31, 2014 | $1.04B | +21.8% |
| 2013 | Dec 31, 2013 | $853.13M | +168.5% |
| 2012 | Dec 31, 2012 | $317.71M | +113.2% |
| 2011 | Dec 30, 2011 | $149.02M | – |
See a number that looks wrong?